Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registry

Mitsuaki Sawano, Shun Kosaka, Takayuki Abe, Taku Inohara, Yuichiro Maekawa, Ikuko Ueda, Koichiro Sueyoshi, Masahiro Suzuki, Shigetaka Noma, Yohei Numasawa, Hiroaki Miyata, Keiichi Fukuda, Kim G. Smolderen, John A. Spertus

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Statin therapy is regarded as an effective medication to reduce cardiovascular events in patients at higher risk for future incidence of coronary artery disease. However, very few studies have been conducted to examine its implementation in non-Western real-world practice. In this study, we sought to describe statin prescription patterns in relation to patient characteristics in a Japanese multicenter percutaneous coronary intervention (PCI) registry as a foundation for quality improvement. We studied 15,024 patients that were prospectively enrolled in the Japan Cardiovascular Database-Keio interhospital Cardiovascular Study Registry from January 2009 to August 2014. The overall discharge statin non-prescription rate was 15.2%, without significant interhospital (MOR = 1.01) or annual differences (MOR = 1.13) observed. Hierarchical multivariable logistic regression analysis accounting for regional differences revealed that the presence of chronic kidney disease was associated with higher rates of statin non-prescription (OR 1.87, 95% confidence interval, 1.69–2.08, p value <0.001), and higher age (per 1-year increase) showed a trend for prescription of low-intensity statin (OR 1.00, 95% confidence interval, 1.00–1.01, p value = 0.045) within the subset of PCI patients (N = 4,853) enrolled after the year 2011. Our study indicates that patients with chronic kidney disease and elderlies may be the primary targets for maximizing the beneficial effect of statin therapy in post PCI patients.

Original languageEnglish
Article numbere0182687
JournalPLoS One
Volume12
Issue number8
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Percutaneous Coronary Intervention
Registries
Coronary Artery Disease
kidney diseases
Chronic Renal Insufficiency
Prescriptions
confidence interval
Confidence Intervals
therapeutics
Quality Improvement
Regression analysis
drug therapy
coronary artery disease
Logistics
Japan
regression analysis
Logistic Models
Regression Analysis
Databases

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Patterns of statin non-prescription in patients with established coronary artery disease : A report from a contemporary multicenter Japanese PCI registry. / Sawano, Mitsuaki; Kosaka, Shun; Abe, Takayuki; Inohara, Taku; Maekawa, Yuichiro; Ueda, Ikuko; Sueyoshi, Koichiro; Suzuki, Masahiro; Noma, Shigetaka; Numasawa, Yohei; Miyata, Hiroaki; Fukuda, Keiichi; Smolderen, Kim G.; Spertus, John A.

In: PLoS One, Vol. 12, No. 8, e0182687, 01.08.2017.

Research output: Contribution to journalArticle

Sawano, Mitsuaki ; Kosaka, Shun ; Abe, Takayuki ; Inohara, Taku ; Maekawa, Yuichiro ; Ueda, Ikuko ; Sueyoshi, Koichiro ; Suzuki, Masahiro ; Noma, Shigetaka ; Numasawa, Yohei ; Miyata, Hiroaki ; Fukuda, Keiichi ; Smolderen, Kim G. ; Spertus, John A. / Patterns of statin non-prescription in patients with established coronary artery disease : A report from a contemporary multicenter Japanese PCI registry. In: PLoS One. 2017 ; Vol. 12, No. 8.
@article{56537260b2e04636a53853eeb1fff2b2,
title = "Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registry",
abstract = "Statin therapy is regarded as an effective medication to reduce cardiovascular events in patients at higher risk for future incidence of coronary artery disease. However, very few studies have been conducted to examine its implementation in non-Western real-world practice. In this study, we sought to describe statin prescription patterns in relation to patient characteristics in a Japanese multicenter percutaneous coronary intervention (PCI) registry as a foundation for quality improvement. We studied 15,024 patients that were prospectively enrolled in the Japan Cardiovascular Database-Keio interhospital Cardiovascular Study Registry from January 2009 to August 2014. The overall discharge statin non-prescription rate was 15.2{\%}, without significant interhospital (MOR = 1.01) or annual differences (MOR = 1.13) observed. Hierarchical multivariable logistic regression analysis accounting for regional differences revealed that the presence of chronic kidney disease was associated with higher rates of statin non-prescription (OR 1.87, 95{\%} confidence interval, 1.69–2.08, p value <0.001), and higher age (per 1-year increase) showed a trend for prescription of low-intensity statin (OR 1.00, 95{\%} confidence interval, 1.00–1.01, p value = 0.045) within the subset of PCI patients (N = 4,853) enrolled after the year 2011. Our study indicates that patients with chronic kidney disease and elderlies may be the primary targets for maximizing the beneficial effect of statin therapy in post PCI patients.",
author = "Mitsuaki Sawano and Shun Kosaka and Takayuki Abe and Taku Inohara and Yuichiro Maekawa and Ikuko Ueda and Koichiro Sueyoshi and Masahiro Suzuki and Shigetaka Noma and Yohei Numasawa and Hiroaki Miyata and Keiichi Fukuda and Smolderen, {Kim G.} and Spertus, {John A.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1371/journal.pone.0182687",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Patterns of statin non-prescription in patients with established coronary artery disease

T2 - A report from a contemporary multicenter Japanese PCI registry

AU - Sawano, Mitsuaki

AU - Kosaka, Shun

AU - Abe, Takayuki

AU - Inohara, Taku

AU - Maekawa, Yuichiro

AU - Ueda, Ikuko

AU - Sueyoshi, Koichiro

AU - Suzuki, Masahiro

AU - Noma, Shigetaka

AU - Numasawa, Yohei

AU - Miyata, Hiroaki

AU - Fukuda, Keiichi

AU - Smolderen, Kim G.

AU - Spertus, John A.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Statin therapy is regarded as an effective medication to reduce cardiovascular events in patients at higher risk for future incidence of coronary artery disease. However, very few studies have been conducted to examine its implementation in non-Western real-world practice. In this study, we sought to describe statin prescription patterns in relation to patient characteristics in a Japanese multicenter percutaneous coronary intervention (PCI) registry as a foundation for quality improvement. We studied 15,024 patients that were prospectively enrolled in the Japan Cardiovascular Database-Keio interhospital Cardiovascular Study Registry from January 2009 to August 2014. The overall discharge statin non-prescription rate was 15.2%, without significant interhospital (MOR = 1.01) or annual differences (MOR = 1.13) observed. Hierarchical multivariable logistic regression analysis accounting for regional differences revealed that the presence of chronic kidney disease was associated with higher rates of statin non-prescription (OR 1.87, 95% confidence interval, 1.69–2.08, p value <0.001), and higher age (per 1-year increase) showed a trend for prescription of low-intensity statin (OR 1.00, 95% confidence interval, 1.00–1.01, p value = 0.045) within the subset of PCI patients (N = 4,853) enrolled after the year 2011. Our study indicates that patients with chronic kidney disease and elderlies may be the primary targets for maximizing the beneficial effect of statin therapy in post PCI patients.

AB - Statin therapy is regarded as an effective medication to reduce cardiovascular events in patients at higher risk for future incidence of coronary artery disease. However, very few studies have been conducted to examine its implementation in non-Western real-world practice. In this study, we sought to describe statin prescription patterns in relation to patient characteristics in a Japanese multicenter percutaneous coronary intervention (PCI) registry as a foundation for quality improvement. We studied 15,024 patients that were prospectively enrolled in the Japan Cardiovascular Database-Keio interhospital Cardiovascular Study Registry from January 2009 to August 2014. The overall discharge statin non-prescription rate was 15.2%, without significant interhospital (MOR = 1.01) or annual differences (MOR = 1.13) observed. Hierarchical multivariable logistic regression analysis accounting for regional differences revealed that the presence of chronic kidney disease was associated with higher rates of statin non-prescription (OR 1.87, 95% confidence interval, 1.69–2.08, p value <0.001), and higher age (per 1-year increase) showed a trend for prescription of low-intensity statin (OR 1.00, 95% confidence interval, 1.00–1.01, p value = 0.045) within the subset of PCI patients (N = 4,853) enrolled after the year 2011. Our study indicates that patients with chronic kidney disease and elderlies may be the primary targets for maximizing the beneficial effect of statin therapy in post PCI patients.

UR - http://www.scopus.com/inward/record.url?scp=85027699490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027699490&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0182687

DO - 10.1371/journal.pone.0182687

M3 - Article

C2 - 28817616

AN - SCOPUS:85027699490

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0182687

ER -